medigraphic.com

2020, Number 3

<< Back Next >>

Rev Clin Esc Med 2020; 10 (3)

Nefrolitiasis: Una revisión actualizada

Herrera MÁA, Álvarez CNA, Jiménez SR, Morelli MIE, Ruiz SED, Salazar CV, Soto CGM

Language: Spanish
References: 23
Page: 11-18
PDF size: 273.07 Kb.


ABSTRACT

Kidney stones are solid accumulations of different mineral salts incorporated into an organic matrix, which originate in the kidney or upper urinary tract. There are different types according to their main component, with calcium being the most prevalent. The incidence is higher in middleaged men, which also have a higher risk of recurrence. Among the most important risk factors are alterations in the urinary concentration of minerals, metabolic syndrome and low water consumption. The most frequent clinical manifestations are pain, hematuria and bacteriuria; however, the majority of cases are asymptomatic. The gold standard for diagnosis is computerized axial tomography (CAT) scan without contrast. Regarding treatment, it includes the pharmacological approach with nonsteroidal anti-inflammatory (NSAIDs) drugs and surgical management according to the type of kidney stone. Two of the most important complications are acute renal failure and chronic kidney disease, which cause significant morbidity and mortality; making prevention through proper hydration, low sodium and reduced animal protein intake and a normal calcium level diet vital for clinical management.


REFERENCES

  1. González G. Litiasis renal: estudio y manejo endocrinológico. Rev. Med. Clin. Condes 2013; 24(5): 798-803.

  2. Kasper D, et al. Harrison. Principios de Medicina Interna. 2016; 13: 342.

  3. Orozco B, Camaggi M. Evaluación metabólica y nutricional en litiasis renal. Revista Médica Clínica Las Condes 2010; 21(4): 567-577.

  4. Dos Santos V, Burgos F. Litiasis en el origen de insuficiencia renal crónica. Nefrología 2005; 25: 82- 88.

  5. Barquero G, Briceño L. Análisis Metabólico y Químico de la Urolitiasis, en dos Hospitales Centrales de Costa Rica. 2005; 1, 15-24.

  6. Calestroupat J, Djelouat T, Costa P. Manifestaciones clínicas de la litiasis urinaria. EMC-Urología 2010; 42(2): 1-10.

  7. Peña J. Avances y retos en la fisiopatología y tratamiento de la nefrolitiasis. Acta médica Grupo Ángeles 2016; 14(3): 155-161.

  8. Worcester E, Coe F. Calcium kidney stones. N Engl J Med. 2010; 363(10): 954-963.

  9. Türk C, Neisius A, Petrick A, et al. EAU Guidelines on Urolithiasis. European Association of Urology 2018: 7-30.

  10. Potretzke A, Monga M. Imaging modalities for urolithiasis: impact on management. Current Opinion in Urology. 2008; 18(2): 199-203.

  11. Pearle M, Goldfarb D, Assimos D, et al. Medical Management of Kidney Stones: AUA Guideline. AUA 2014.

  12. Diri A, Diri B. Management of staghorn renal stones. Renal Failure. 2018; 40(1): 357-362.

  13. Mulay S, Anders H. Crystal nephropathies: mechanisms of crystal-induced kidney injury. Nature Reviews Nephrology 2017; 13(4): 226-240.

  14. Rule A, Bergstrahl E, Melton J, Xujian J, Weaver A, Lieske J. Kidney Stones and the Risk for Chronic Kidney Disease. Clin J Am Soc Nephrol 2019; 4: 804- 811.

  15. Sakhaee K. Nephrolithiasis as a systemic disorder. Current Opinion in Nephrology and Hypertension 2008; 17(3): 304-309.

  16. Khan S. Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome? Urological Research 2012; 40(2): 95-112

  17. Zisman A, Evan A, Coe F, Worcester E. Do kidney stone formers have a kidney disease? Kidney International 2015; 88(6): 1240-1249.

  18. Maalouf NM, Cameron MA, Moe OW, et al. Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol 2007; 2:883-888

  19. Eisner BH, Cooperberg MR, Curhan GC, et al. Neprolithiasis and the risk of cardiovascular disease. J Urol 2007; 177:449

  20. Fink H, Akornor J, Garimella P, et al. Diet, Fluid, or Supplements for Secondary Prevention of Nephrolithiasis: A Systematic Review and Meta- Analysis of Randomized Trials. Eur Urol 2009; 56(1): 72–80.

  21. Trinchieri A, Croppi E, Montanari E. Obesity and urolithiasis: evidence of regional influences. Springer 2016; 45(3): 271-278.

  22. Sorensen M, Chi T, Shara N, et al. Activity, Energy Intake, Obesity, and the Risk of Incident Kidney Stones in Postmenopausal Women: A Report from the Women’s Health Initiative. J Am Soc Nephrol 2014; 25: 362-369.

  23. Ratkalkar V, Kleinman J. Mechanisms of Stone Formation. Clin Rev Bone Miner Metab 2011; 9(3-4): 187-197.




2020     |     www.medigraphic.com